Search results for "From ACP Internist Weekly"


 
Results 31 - 40 of about 69 for "From ACP Internist Weekly".
Sort by: Relevance | Newest | Oldest

Tailoring diabetes screening by race, ethnicity may lead to earlier diagnosis

Researchers used data from the National Health and Nutrition Examination Survey to determine the body mass index and age thresholds for diabetes screening in major racial/ethnic minority populations.
https://diabetes.acponline.org/archives/2022/05/13/8.htm
13 May 2022

Lifestyle modification may outperform medications over time for diabetes prevention, meta-analysis finds

Twenty-five people would need to be treated with lifestyle modification to prevent one diabetes case, according to the analysis of randomized clinical trials that evaluated lifestyle modification and medication interventions for diabetes prevention in at-risk adults.
https://diabetes.acponline.org/archives/2017/12/08/6.htm
8 Dec 2017

No additional benefit seen for self-monitored blood glucose with community health worker support

In a small trial, patients with insulin-treated diabetes were randomly assigned to usual care, a lottery incentive for daily self-monitored blood glucose, or the lottery plus support from a community health worker if needed.
https://diabetes.acponline.org/archives/2022/06/10/6.htm
10 Jun 2022

Newer, older insulin formulations may offer similar glucose-lowering effects

The findings may help inform decisions about insulin therapy for patients with type 2 diabetes, for example, when minimizing weight gain or nocturnal hypoglycemia is a priority.
https://diabetes.acponline.org/archives/2018/07/13/8.htm
13 Jul 2018

Preoperative factors may help predict long-term weight outcomes after gastric bypass, study finds

Only 3 factors were associated with greater long-term weight loss: preoperative insulin use, history of smoking, and use of 12 or more medications before surgery.
https://diabetes.acponline.org/archives/2016/09/16/6.htm
16 Sep 2016

Task Force releases systematic review about diabetes screening

A systematic evidence review by the U.S. Preventive Services Task Force suggests that screening asymptomatic adults for elevated glucose levels could help delay progression to diabetes but has not been shown to improve mortality rates.
https://diabetes.acponline.org/archives/2015/06/12/6.htm
12 Jun 2015

Diabetes Collaborative Registry seeks primary care participants

ACP has partnered with the American College of Cardiology to participate in the Diabetes Collaborative Registry, a national clinical diabetes registry and interdisciplinary collaboration designed to assess and improve the quality of a practice's diabetes care for free.
https://diabetes.acponline.org/archives/2015/08/14/8.htm
14 Aug 2015

SGLT-2 inhibitors associated with lower risk of gout vs. GLP-1 receptor agonists

In a large, propensity-matched study, adult patients with type 2 diabetes who were newly prescribed a sodium-glucose cotransporter-2 (SGLT-2) inhibitor had a lower rate of incident gout than those newly prescribed a glucagon-like peptide-1 (GLP-1) receptor agonist.
https://diabetes.acponline.org/archives/2020/02/14/7.htm
14 Feb 2020

Primary care-based weight-loss program led to remission of type 2 diabetes

At the end of 12 months, 36 intervention participants lost 15 kg or more, compared to no participants in the control group, and diabetes remission was associated with the amount of weight lost.
https://diabetes.acponline.org/archives/2018/01/12/11.htm
12 Jan 2018

New recommendations advise on adding SGLT-2 inhibitors and GLP-1 receptor agonists

A new guideline from The BMJ strongly recommends sodium-glucose cotransporter-2 (SGLT-2) inhibitors for patients with diabetes and established cardiovascular and chronic kidney disease, in addition to offering weaker support for starting glucagon-like peptide-1 (GLP-1) receptor agonists in this same patient population.
https://diabetes.acponline.org/archives/2021/06/11/7.htm
11 Jun 2021

Result Page: Prev   1   2   3   4   5   6   7   Next